Literature DB >> 18408757

Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer.

H Ogiwara1, T Kohno, H Nakanishi, K Nagayama, M Sato, J Yokota.   

Abstract

Loss of heterozygosity (LOH) is a major genetic event causing inactivation of tumor suppressor genes in human carcinogenesis. To elucidate chromosomal mechanisms causing LOH, 201 LOHs in 10 cases of human lung cancer, which were detected by a genome-wide single nucleotide polymorphism array analysis, were investigated for responsible chromosome alterations by integrating information on breakpoints for DNA copy number changes obtained by array-comparative genome hybridization and on numerical and structural chromosomal alterations obtained by spectral karyotyping. The majority (80%) of LOHs were partial chromosome LOHs caused by structural chromosomal alterations, while the remaining (20%) were whole chromosome LOHs caused by whole chromosome deletions. Unbalanced translocation was defined as the most frequent alteration, and it accounted for 30% of all LOHs. Three other structural alterations-interstitial deletion (19%), mitotic recombination (9%) and gene conversion (6%)-also contributed to the occurrence of LOH, while terminal deletion contributed to only a small subset (1%). Since unbalanced translocation is a common chromosomal alteration in lung cancer cells, the results in the present study strongly indicate that a considerable fraction of LOHs detected in lung cancer cells are caused by unbalanced translocation.

Entities:  

Mesh:

Year:  2008        PMID: 18408757     DOI: 10.1038/onc.2008.113

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.

Authors:  Xiao-Jie Ding; Min-Xia Liu; Lei Ao; Yi-Rong Liang; Yi Cao
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

Review 2.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Authors:  Adi F Gazdar; Boning Gao; John D Minna
Journal:  Lung Cancer       Date:  2010-01-15       Impact factor: 5.705

Review 3.  The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club.

Authors:  Isabelle Opitz; Thomas A D'Amico; Gaetano Rocco
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

4.  Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer.

Authors:  Jong Y Park; Donghwa Kim; Mihi Yang; Hyun Y Park; Sang Haak Lee; Maria Rincon; Jenny Kreahling; Christoph Plass; Dominic J Smiraglia; Melvyn S Tockman; Seung Joon Kim
Journal:  Lung Cancer       Date:  2012-12-27       Impact factor: 5.705

5.  11q21.1-11q23.3 Is a site of intrinsic genomic instability triggered by irradiation.

Authors:  Nga Du; Pamela M Baker; To Uyen Do; Christine Bien; Carol M Bier-Laning; Sheetal Singh; Shyh-Jen Shih; Manual O Diaz; Andrew T Vaughan
Journal:  Genes Chromosomes Cancer       Date:  2010-09       Impact factor: 5.006

6.  Identification of lung cancer with high sensitivity and specificity by blood testing.

Authors:  Petra Leidinger; Andreas Keller; Sabrina Heisel; Nicole Ludwig; Stefanie Rheinheimer; Veronika Klein; Claudia Andres; Andrea Staratschek-Jox; Jürgen Wolf; Erich Stoelben; Bernhard Stephan; Ingo Stehle; Jürg Hamacher; Hanno Huwer; Hans-Peter Lenhof; Eckart Meese
Journal:  Respir Res       Date:  2010-02-10

7.  A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.

Authors:  Takashi Kohno; Ayaka Otsuka; Luc Girard; Masanori Sato; Reika Iwakawa; Hideaki Ogiwara; Montse Sanchez-Cespedes; John D Minna; Jun Yokota
Journal:  Genes Chromosomes Cancer       Date:  2010-04       Impact factor: 5.006

Review 8.  Inflammation-induced DNA damage, mutations and cancer.

Authors:  Jennifer Kay; Elina Thadhani; Leona Samson; Bevin Engelward
Journal:  DNA Repair (Amst)       Date:  2019-07-25

9.  Excision of mutagenic replication-blocking lesions suppresses cancer but promotes cytotoxicity and lethality in nitrosamine-exposed mice.

Authors:  Jennifer E Kay; Joshua J Corrigan; Amanda L Armijo; Ilana S Nazari; Ishwar N Kohale; Dorothea K Torous; Svetlana L Avlasevich; Robert G Croy; Dushan N Wadduwage; Sebastian E Carrasco; Stephen D Dertinger; Forest M White; John M Essigmann; Leona D Samson; Bevin P Engelward
Journal:  Cell Rep       Date:  2021-03-16       Impact factor: 9.423

10.  The relative timing of mutations in a breast cancer genome.

Authors:  Scott Newman; Karen D Howarth; Chris D Greenman; Graham R Bignell; Simon Tavaré; Paul A W Edwards
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.